Cargando...
Predicting treatment response in castration-resistant prostate cancer: could androgen receptor variant-7 hold the key?
There is an emerging interest in understanding mechanisms of response and resistance to next-generation hormonal therapies: abiraterone and enzalutamide. While many explanations for resistance to these agents have been postulated, the importance of androgen receptor splice variants is gaining moment...
Gardado en:
| Publicado en: | Expert Rev Anticancer Ther |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4516117/ https://ncbi.nlm.nih.gov/pubmed/25547524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2015.999044 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|